Astec LifeSciences Balance Sheet Health
Financial Health criteria checks 1/6
Astec LifeSciences has a total shareholder equity of ₹4.0B and total debt of ₹4.3B, which brings its debt-to-equity ratio to 109.2%. Its total assets and total liabilities are ₹9.1B and ₹5.1B respectively.
Key information
109.2%
Debt to equity ratio
₹4.31b
Debt
| Interest coverage ratio | n/a |
| Cash | ₹25.50m |
| Equity | ₹3.95b |
| Total liabilities | ₹5.14b |
| Total assets | ₹9.09b |
Recent financial health updates
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Recent updates
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares
Nov 17Financial Position Analysis
Short Term Liabilities: ASTEC's short term assets (₹3.5B) do not cover its short term liabilities (₹3.7B).
Long Term Liabilities: ASTEC's short term assets (₹3.5B) exceed its long term liabilities (₹1.4B).
Debt to Equity History and Analysis
Debt Level: ASTEC's net debt to equity ratio (108.5%) is considered high.
Reducing Debt: ASTEC's debt to equity ratio has increased from 84.1% to 109.2% over the past 5 years.
Debt Coverage: ASTEC's debt is not well covered by operating cash flow (2.3%).
Interest Coverage: Insufficient data to determine if ASTEC's interest payments on its debt are well covered by EBIT.